Skip to main content

Table 1 Baseline characteristics of participants

From: Effects of Sleep-Extend on glucose metabolism in women with a history of gestational diabetes: a pilot randomized trial

 

Sleep-Extend

(n=9)

Healthy living

(n=5)

Mean difference

95% confidence interval

Demographics and self-reported questionnaires

 Age (years)

42.0 (2.9)

38.7 (6.0)

3.3

− 1.8, 8.4

 Number of children living at home

2.2 (0.9)

1.4 (1.3)

0.8

− 0.5, 2.2

 Weight (kg)

85.7 (14.3)

85.7 (13.5)

− 0.01

− 17.1, 17.0

 BMI (kg/m2)

32.7 (5.3)

32.6 (4.6)

0.2

− 5.9, 6.3

 PSQI

7.8 (2.9)

6.4 (3.0)

1.4

− 2.2, 4.9

 GAD-7 score

3.8 (2.3)

0.8 (1.5), n=4

3.0

0.3, 5.8

 Promis Fatigue T-score

52.3 (8.8)

41.7 (6.3), n=4

10.6

− 0.3, 21.3

 IPAQ (MET- minutes/week)

3051 (1945, 3723)

8397 (885, 9252)

 

U=18.0, z= − 0.60

 CES-D

8.9 (3.1)

2.8 (2.2)

6.1

2.6, 9.6

Objectively measured sleep parameters

 Sleep duration (minutes)

369.6 (30.8)

408.9 (18.3)

− 39.3

− 72.4, − 6.1

 Sleep efficiency (%)

88.2 (3.2)

90.7 (2.5)

− 2.5

− 6.1, 1.2

Glycemic parameters

 Fasting glucose (mg/dL)

101.0 (94.0, 106.0)

97.0 (93.0, 100.0)

 

U=14.0, z= − 1.14

 2h glucose (mg/dL)

144.2 (29.9)

136.0 (25.1)

8.2

− 26.4, 42.8

 AUC glucose

304.4 (58.8)

295.4 (26.5)

9.0

− 52.2, 70.3

 HOMA-IR*

3.6 (2.1, 4.4)

1.5 (1.2, 3.9)

 

U=11.0, z=− 1.32

  1. Data are presented as mean (SD) or median (IQR). U and z values are from Mann-Whitney U tests
  2. AUC area under the curve, BMI body mass index, CES-D Center for Epidemiologic Studies Depression Scale, GAD-7 General Anxiety Disorder-7, HOMA-IR Homeostatic Model Assessment for Insulin Resistance, IPAQ International Physical Activity Questionnaire, PSQIPittsburgh Sleep Quality Index
  3. *n=8